| Code | Description | Claims | Beneficiaries | Total Paid |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,618 |
1,325 |
$338K |
| 99443 |
|
4,306 |
3,965 |
$228K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
717 |
586 |
$159K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
226 |
185 |
$68K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
793 |
728 |
$28K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
370 |
349 |
$25K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
192 |
163 |
$18K |
| J2704 |
Injection, propofol, 10 mg |
528 |
459 |
$14K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
581 |
524 |
$12K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
291 |
271 |
$11K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
255 |
227 |
$7K |
| 99442 |
|
150 |
146 |
$6K |
| 99441 |
|
151 |
142 |
$4K |
| 88312 |
|
26 |
26 |
$1K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
95 |
81 |
$560.47 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
15 |
13 |
$237.33 |